These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22618776)

  • 1. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
    Si Y; Zhao Y; Hao H; Liu J; Guo Y; Mu Y; Shen J; Cheng Y; Fu X; Han W
    Diabetes; 2012 Jun; 61(6):1616-25. PubMed ID: 22618776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of adipose‑derived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats.
    Deng Z; Xu H; Zhang J; Yang C; Jin L; Liu J; Song H; Chen G; Han W; Si Y
    Mol Med Rep; 2018 Jun; 17(6):8466-8474. PubMed ID: 29693163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats.
    Paz AH; Salton GD; Ayala-Lugo A; Gomes C; Terraciano P; Scalco R; Laurino CC; Passos EP; Schneider MR; Meurer L; Cirne-Lima E
    Stem Cells Dev; 2011 Feb; 20(2):223-32. PubMed ID: 20836700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats.
    Gao LR; Zhang NK; Zhang Y; Chen Y; Wang L; Zhu Y; Tang HH
    Stem Cell Res Ther; 2018 Dec; 9(1):339. PubMed ID: 30526660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction.
    Sun Y; Shi H; Yin S; Ji C; Zhang X; Zhang B; Wu P; Shi Y; Mao F; Yan Y; Xu W; Qian H
    ACS Nano; 2018 Aug; 12(8):7613-7628. PubMed ID: 30052036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats.
    Xie M; Hao HJ; Cheng Y; Xie ZY; Yin YQ; Zhang Q; Gao JQ; Liu HY; Mu YM; Han WD
    Biochem Biophys Res Commun; 2017 Jan; 483(1):435-441. PubMed ID: 28013047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of acute and chronic exercise on fat PI3K/AKT/GLUT4 signal pathway in type 2 diabetic rats].
    Yi XJ; Sun YX; Yao TT; Li J; Gao C; Liu L; Cao SC; Chang B; Zhang CP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):12-16. PubMed ID: 32476367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord mesenchymal stem cells attenuate diabetic nephropathy through the IGF1R-CHK2-p53 signalling axis in male rats with type 2 diabetes mellitus.
    Zhang H; Wang X; Hu B; Li P; Abuduaini Y; Zhao H; Jieensihan A; Chen X; Wang S; Guo N; Yuan J; Li Y; Li L; Yang Y; Liu Z; Tang Z; Wang H
    J Zhejiang Univ Sci B; 2024 Jul; 25(7):568-580. PubMed ID: 39011677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
    Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
    Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems.
    Kotikalapudi N; Sampath SJP; Sukesh Narayan S; R B; Nemani H; Mungamuri SK; Venkatesan V
    Sci Rep; 2021 Aug; 11(1):16983. PubMed ID: 34417511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells for the treatment of diabetes.
    Pileggi A
    Diabetes; 2012 Jun; 61(6):1355-6. PubMed ID: 22618774
    [No Abstract]   [Full Text] [Related]  

  • 19. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spleen-Derived Anti-Inflammatory Cytokine IL-10 Stimulated by Adipose Tissue-Derived Stem Cells Protects Against Type 2 Diabetes.
    Zhang J; Deng Z; Jin L; Yang C; Liu J; Song H; Han W; Si Y
    Stem Cells Dev; 2017 Dec; 26(24):1749-1758. PubMed ID: 29032727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.